First Trust Advisors
FLGT icon

First Trust Advisors’s Fulgent Genetics FLGT Stock Holding History

First Trust Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-36,190
Closed -$785K – 2359
2024
Q1 		$785K Buy
36,190
+3,067
+9% +$76.2K ﹤0.01% 2038
2023
Q4 		$958K Buy
+33,123
New +$886K ﹤0.01% 1980
2022
Q4 		– Sell
-70,865
Closed -$2.7M – 2467
2022
Q3 		$2.7M Sell
70,865
-6,747
-9% -$338K ﹤0.01% 1536
2022
Q2 		$4.23M Buy
77,612
+26,684
+52% +$1.47M 0.01% 1326
2022
Q1 		$3.18M Buy
50,928
+1,995
+4% +$131K ﹤0.01% 1581
2021
Q4 		$4.92M Sell
48,933
-12,074
-20% -$1.06M ﹤0.01% 1370
2021
Q3 		$5.49M Sell
61,007
-494
-0.8% -$44.9K 0.01% 1258
2021
Q2 		$5.67M Buy
+61,501
New +$4.91M 0.01% 1272

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

First Trust Advisors's FLGT Position: Q2 2024 in Review

First Trust Advisors sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 36,190 shares — an estimated $785K sold.

First Trust Advisors first reported a position in FLGT in Q2 2021 and held it in 8 quarters. The position peaked at $5.67M in Q2 2021. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • First Trust Advisors reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • First Trust Advisors sold 36,190 Fulgent Genetics shares in Q2 2024, an estimated $785K.
  • First Trust Advisors first reported a position in Fulgent Genetics in Q2 2021 and held it in 8 quarters.
  • First Trust Advisors's Fulgent Genetics position peaked at $5.67M in Q2 2021.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on First Trust Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.